Home / Stocks / HNGE

Hinge Health (HNGE, Health Care Services) Stock Valuation & Fair Value Significantly overvalued

Hinge Health (HNGE, Health Care Services) trades at a blended P/E of 39.8, about 124% above its historical normal valuation, with a forward growth estimate of 26.1% and a PEG of 1.52. Priced at its historical normal P/E of 17.7 on the same blended earnings, the 2026-09-18 close of $94.90 corresponds to about $42.30 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
39.8
Normal P/E
17.7
PEG
1.52
Fwd growth
26.1%
Div yield
0.0%
RSI (14)
59.0
Neutral

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 28.4 to 39.8 between 2026-07-31 and 2026-09-21, against a normal P/E of 17.7, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 28.4, Significantly overvalued (recalculated)2026-08-03: P/E 28.2, Significantly overvalued2026-08-07: P/E 28.2, Significantly overvalued (recalculated)2026-08-10: P/E 36.9, Significantly overvalued2026-08-14: P/E 36.9, Significantly overvalued (recalculated)2026-08-17: P/E 36.6, Significantly overvalued2026-08-21: P/E 36.6, Significantly overvalued (recalculated)2026-08-24: P/E 36.6, Significantly overvalued2026-08-27: P/E 36.6, Significantly overvalued (recalculated)2026-08-28: P/E 36.6, Significantly overvalued (recalculated)2026-08-30: P/E 36.6, Significantly overvalued (recalculated)2026-08-31: P/E 36.3, Significantly overvalued2026-09-05: P/E 36.3, Significantly overvalued (recalculated)2026-09-07: P/E 38.5, Significantly overvalued2026-09-12: P/E 38.5, Significantly overvalued (recalculated)2026-09-14: P/E 37.0, Significantly overvalued2026-09-19: P/E 37.0, Significantly overvalued (recalculated)2026-09-21: P/E 39.8, Significantly overvalued20.030.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 17.7
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 28.4+60%Significantly overvalued
2026-08-03P/E 28.2+59%Significantly overvalued
2026-09-21P/E 39.8+124%Significantly overvalued ← now

Frequently asked questions

Is Hinge Health stock overvalued?

At a blended P/E of 39.8 versus its historical normal P/E of 17.7, Hinge Health trades about 124% above its typical valuation, with a PEG of 1.52 on 26.1% forward growth. tickerseer currently rates it significantly overvalued.

What is Hinge Health's fair value and PEG?

Hinge Health trades at a blended P/E of 39.8 against a historical normal P/E of 17.7, a PEG of 1.52, and a forward growth estimate of 26.1%. Priced at its historical normal P/E of 17.7 on the same blended earnings, the 2026-09-18 close of $94.90 corresponds to about $42.30 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Hinge Health changed?

tickerseer's rating has been significantly overvalued since 2026-07-31.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track HNGE free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.